Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Please tell us more about yourself below so we can offer you customized information, updates on living with diabetes, and ongoing support.
If you prefer to register by phone, you can call 1‑800‑727‑6500 Monday through Friday from 8:30 am to 6:00 pm to enroll with one of our professionals.
Please tell us more about yourself below so we can offer you customized information, updates on living with diabetes, and ongoing support.
If you prefer to register by phone, you can call 1‑800‑727‑6500 Monday through Friday from 8:30 am to 6:00 pm to enroll with one of our professionals.
Let's get started
Let's get started
Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Ozempic® may cause serious side effects, including:
Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used:
It is not known if Ozempic® can be used in people who have had pancreatitis.
Ozempic® is not for use in people with type 1 diabetes.
It is not known if Ozempic® is safe and effective for use in children under 18 years of age.
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
Ozempic® may cause serious side effects, including:
The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.
Please see Prescribing Information and Medication Guide for Ozempic®.
Ozempic® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
RYBELSUS® may cause serious side effects, including:
Do not use RYBELSUS® if:
RYBELSUS® (semaglutide) tablets 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
Before using RYBELSUS®, tell your healthcare provider if you have any other medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RYBELSUS® may affect the way some medicines work and some medicines may affect the way RYBELSUS® works.
RYBELSUS® may cause serious side effects, including:
The most common side effects of RYBELSUS® may include nausea, stomach (abdominal) pain, diarrhea, decreased appetite, vomiting, and constipation. Nausea, vomiting, and diarrhea are most common when you first start RYBELSUS®.
Please see Prescribing Information and Medication Guide for RYBELSUS®.
RYBELSUS® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Victoza® may cause serious side effects, including:
Do not use Victoza® if:
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is an injectable prescription medicine used:
Victoza® is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if Victoza® is safe and effective to lower blood sugar in children under 10 years of age.
Before using Victoza®, tell your health care provider if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
Victoza® may cause serious side effects, including:
The most common side effects of Victoza® may include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation.
Please see Prescribing Information and Medication Guide for Victoza®.
Victoza® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Xultophy® 100/3.6 may cause serious side effects, including:
Xultophy® 100/3.6 is an injectable prescription medicine that contains 2 diabetes medicines, insulin degludec, 100 units/mL, and liraglutide, 3.6 mg/mL. Xultophy® 100/3.6 should be used along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes mellitus.
Do not use Xultophy® 100/3.6 if:
Tell your health care provider about all your medical conditions, including if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Before using Xultophy® 100/3.6, talk to your health care provider about low blood sugar and how to manage it.
Your dose of Xultophy® 100/3.6 may need to change because of change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or other medicines you take.
Xultophy® 100/3.6 may cause serious side effects that can be life-threatening, including:
The most common side effects of Xultophy® 100/3.6 may include stuffy or runny nose, sore throat, headache, nausea, diarrhea, increased blood levels of lipase, and upper respiratory tract infection.
Please see Prescribing Information and Medication Guide for Xultophy® 100/3.6.
Xultophy® 100/3.6 is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your Fiasp® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Do not take Fiasp® if:
Before taking Fiasp® tell your health care provider about all your medical conditions including, if you:
Talk to your health care provider about low blood sugar and how to manage it.
Change (rotate) your injection sites within the area you choose with each injection to reduce your risk of getting pits in skin or thickened skin (lipodystrophy) and skin with lumps (localized cutaneous amyloidosis) at the injection sites.
Serious side effects can lead to death, including:
Your insulin dose may need to change because of:
Common side effects of Fiasp® may include:
Please see Prescribing Information for Fiasp®.
Fiasp® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your Levemir® FlexPen® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection or get a serious infection from them.
Do not take Levemir® if:
Before taking Levemir®, tell your healthcare provider about all your medical conditions including, if you:
Tell your healthcare provider all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Before you start taking Levemir®, talk to your healthcare provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Other common side effects include:
Your insulin dose may need to change because of:
Please see Prescribing Information for Levemir®.
Levemir® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your NovoLog® FlexPen®, NovoLog® FlexTouch®, PenFill® cartridge or PenFill® cartridge compatible insulin delivery device with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Do not take NovoLog® if:
Before taking NovoLog®, tell your health care provider about all your medical conditions including, if you are:
Talk to your health care provider about how to manage low blood sugar.
Serious side effects can lead to death, including:
Low blood sugar. Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please see Prescribing Information for NovoLog®.
NovoLog® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your NovoLog® Mix 70/30 FlexPen® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Before taking NovoLog® Mix 70/30, tell your healthcare provider about all your medical conditions including, if you are:
Before you start taking NovoLog® Mix 70/30, talk to your health care provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Low blood sugar (hypoglycemia). Some signs and symptoms include:
Your insulin dose may need to change because of:
Other common side effects may include:
Get emergency medical help if you have:
Please see Prescribing Information for NovoLog® Mix 70/30.
NovoLog® Mix 70/30 is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not take Tresiba® if you:
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are:
Talk to your health care provider about low blood sugar and how to manage it.
Tresiba® may cause serious side effects that can be life-threatening, including:
Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness.
Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.
Please see Prescribing Information for Tresiba®.
Tresiba® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your Novolin® R FlexPen® or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not take Novolin® R if:
Before taking Novolin® R, tell your healthcare provider about all your medical conditions including, if you:
Tell your healthcare provider all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Before you start taking Novolin® R, talk to your healthcare provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Get emergency medical help if you have:
The common side effects of Novolin® R include:
Your Novolin® R dose may need to change because of:
Please see Prescribing Information for Novolin® R.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your Novolin® N FlexPen® or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not take Novolin® N if:
Before taking Novolin® N, tell your healthcare provider about all your medical conditions including, if you:
Tell your healthcare provider all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Before you start taking Novolin® N, talk to your healthcare provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Get emergency medical help if you have:
The common side effects of Novolin® N include:
Your Novolin® N dose may need to change because of:
Please see Prescribing Information for Novolin® N.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Do not share your Novolin® 70/30 FlexPen® or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Do not take Novolin® 70/30 if:
Before taking Novolin® 70/30, tell your healthcare provider about all your medical conditions including, if you:
Tell your healthcare provider all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Before you start taking Novolin® 70/30, talk to your healthcare provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Get emergency medical help if you have:
The common side effects of Novolin® 70/30 include:
Your Novolin® 70/30 dose may need to change because of:
Please see Prescribing Information for Novolin® 70/30.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Loading....